4.5.34.8 Esketamine Treatment

Esketamine is indicated for adults with treatment-resistant major depression who have not responded adequately to at least two different antidepressants, taken at an appropriate dose and duration for their current moderate to severe depressive episode.

Esketamine is not considered first line treatment for depression and should only be considered when other treatments such as psychotherapy or medications do not provide adequate benefit.

WorkSafe will only consider esketamine treatment when delivered by an esketamine accredited psychiatrist. The treating psychiatrist may refer the worker to a clinic where eketamine is delivered under the care of an esketamine accredited psychiatrist.

Guidelines

Refer to the Esketamine guidelines for more information including:

  • what WorkSafe can pay for

  • services WorkSafe will not pay for

  • how much WorkSafe can pay

  • who can provide these treatments

  • accessing treatment

  • treatment delivery expectations

These guidelines should be read in conjunction with:

Next | Back to top